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Mouse models
Metastasis
Comparative microarrays
Gene signaturesTo investigate the molecular basis underlying aggressive behavior in oral squamous cell carcinoma (OSCC), our
laboratory developed a carcinogen-induced mouse oral cancer (MOC) cell line model that encompasses the
growth and metastasis spectrum of its human counterpart. We performed next-generation sequencing (NGS)
and gene expressionmicroarray proﬁles to explore the genomic and transcriptional backgrounds of the differen-
tial MOC line phenotypes, as well as, the cross-species relevance of the model. Here we describe the comparative
analysis of NGS (www.ncbi.nlm.nih.gov/biosample?LinkName=bioproject_biosample_all&from_uid=247825)
and expression microarray (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50041) data from the MOC
lines and corresponding human data, as described in our recent publication [1].
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Experimental design, materials and methods
Cell lines
We have previously described a 7,12 dimethylbenzanthracene
(DMBA)-induced mouse cell line model of OSCC where individual
lines display ﬁxed in vivo phenotypes [2]. We classiﬁed these lines
into indolent or aggressive subtypes based on their in vivo growth
patterns in syngeneic mice. Indolent lines formed primary tumors
at orthotopic and heterotopic injection sites but did not display
evidence of metastasis. By contrast the aggressive lines all displayed
regional lymph node as well as occasional lung metastases. Further
genotyping analysis revealed that the three aggressive lines were
related with MOC2-7 and MOC2-10 being derived from the MOC2
line.
Sequencing
MOC lines were grown in deﬁned media and used for genomic
DNA preparation, while CXCR3−/− DNA was generated from mousethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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with their standard platforms and resulted in excellent depth of cover-
age. A critical point in the analysis was due to the lack of control tissue
available from the original mice bearing the parental tumors. Thus, mu-
tation reads were normalized to the reference C57BL/6 genome and a
genomic database of 17 commonly used strains of inbred laboratory
mice.
Human mutational data from all oral squamous cell carcinoma
(OSCC) cases were acquired from published data, The Cancer Genome
Atlas (TCGA), The Broad Institute platform, and from cBioPortal
(http://www.cbioportal.org/public-portal/).Sequencing quality control and analysis
Analysis of sequencing data is described in detail in our publication
[1]. We excluded the common and well-known variants using the
dbSNP ﬁlter, and the novel variants were manually reviewed to de-
crease the false discovery rate. With the goal of further understanding
the signatures of metastasis and identifying immune targets, we per-
formed Varscan copy number analysis and recurrent gene analysis.
We also performed clonality analysis using the point mutations to re-
veal the subclonal architecture within the cell lines.
Growth phenotype-speciﬁc mutations, and comparative analysis
between aggressive versus indolent MOC lines, and lymph nodemetas-
tasis negative versus lymph node positive TCGA OSCC samples, were
established in Microsoft Excel using IF and VLOOKUP commands. The
prevalence of speciﬁc mutations in human OSCC cases from TCGA was
determined using cBioPortal.Microarray
Primary oral keratinocyteswere generated by harvesting oralmucosa
from C57BL/6 mice. The mucosa was digested overnight in Dispase
(Roche) and epithelial layers were then microdissected. Epithelium
was then brieﬂy digested with trypsin (HyClone) and single cell suspen-
sions were generated. These cells were then grown in specialized media
(CellNTec) until near conﬂuent cultureswere obtained. Cellswere subse-
quently grown for 24 h inMOC cell line media. Total RNAwas generated
from 3 to 4 independent cultures of MOC lines and two independent cul-
tures of primary oral keratinocytes using the RNeasy Kit (Qiagen). RNA
qualitywas assessed using Agilent Nano Chips and sampleswith RNA in-
tegrity values of 8–10 were subsequently submitted for gene expression
proﬁling using Illumina MouseRef-8 Expression BeadChips. Raw expres-
sion data were normalized using the cubic spline method in Genome-
Studio 2011.1.
Human OSCC expression data were acquired from four independent
published databases (UW/FHCRC, MD Anderson [3], University of
Pennsylvania [4] and TCGA). Only proven human papilloma virus nega-
tive cases were included. Tumor stage or regional lymph nodemetasta-
sis status were used to categorize aggressive versus indolent cases.Microarray analysis
The normalized expression data were imported into Partek Geno-
mics Suite 6.6. Further analysis is described in our recent publication
and resulted in the identiﬁcation of gene sets representing amouse signa-
ture of aggressiveness [1]. Iterative and tandem gene set enrichment
analysis (GSEA) was used to ﬁnd overlap of the mouse signature genes
in three human datasets, and to eliminate mouse-speciﬁc transcripts.
This process trimmed the number of cross-species relevant transcripts
to 188 genes.
Discussion
We describe here our two-fold genomic approach, of exome se-
quencing and expression microarray, to expose mutational and tran-
scriptional alterations and to delineate the genetic basis of aggressive
growth in ourmurine OSCCmodel. By performing a comparative analy-
siswithhumangenomic andgeneexpressiondata,we found (1) overlap
with themost commonlymutated genes in human HNSCC, (2) new po-
tential driver mutations, (3) novel candidate genes with transcriptional
changes associatedwith aggressive growth, and (4) a cross-species con-
served 118-gene signature predictive of aggressive disease and metas-
tasis in OSCC. These data support the use of carcinogen-induced
mouse oral cancer cell lines as a high-ﬁdelity model of the human
counterpart.
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